STI-571 (Gleevec) in the treatment of chronic myeloid leukaemia.

Simple item page
dc.contributor.authorKumar, Laliten_US
dc.contributor.authorKumari, Mamtaen_US
dc.contributor.authorMenon, Harien_US
dc.date.accessioned2002-09-28en_US
dc.date.accessioned2009-06-03T06:48:31Z
dc.date.available2002-09-28en_US
dc.date.available2009-06-03T06:48:31Z
dc.date.issued2002-09-28en_US
dc.identifier.citationKumar L, Kumari M, Menon H. STI-571 (Gleevec) in the treatment of chronic myeloid leukaemia. National Medical Journal of India. 2002 Sep-Oct; 15(5): 298en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/119291
dc.language.isoengen_US
dc.source.urihttps://www.nmji.inen_US
dc.subject.meshAdulten_US
dc.subject.meshAntineoplastic Agents --adverse effectsen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshLeukemia, Myelogenous, Chronic, BCR-ABL Positive --drug therapyen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPiperazines --adverse effectsen_US
dc.subject.meshPyrimidines --adverse effectsen_US
dc.titleSTI-571 (Gleevec) in the treatment of chronic myeloid leukaemia.en_US
dc.typeLetteren_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
National Medical Journal of India